This study examined the role of acetylcholine for skeletal muscle blood flow during exercise by use of the competitive neuromuscular blocking agent cisatracurium in combination with the acetylcholine receptor blocker glycopyrrone. Nine healthy male subjects performed a 10-min bout of one-legged knee-extensor exercise ( 
Introduction
Regulation of blood flow to contracting muscle remains incompletely understood.
Several locally formed compounds have been suggested to directly or indirectly cause relaxation of the smooth muscle of the vessels in the active muscles.
Moreover, a close relationship between arterial oxygen delivery, energy demand and blood flow indicates that oxygen is a critical factor for the regulation of exercise hyperemia (11, 20) . One compound that has been shown to be a potent mediator of vasodilation in skeletal muscle is acetylcholine. Acetylcholine acts on muscarinic receptors on the endothelium leading to the release of vasodilators such as nitric oxide (NO) and prostanoids (8) . Acetylcholine is also one of the most reliable inducers of conducted vasodilation, a mechanism where vasodilation travels up-or downstream in the endothelial cell layer or the smooth muscle cells of the arteriolar wall via gap-junctional communication (21) . Thus, it is likely that acetylcholine is involved in skeletal muscle blood flow regulation, and yet, the importance of acetylcholine for skeletal muscle vasodilation has been questioned (4) . In two human studies, infusion of the acetylcholine receptor blocker atropine was shown to have either none, or a minor, effect on forearm blood flow in response to muscle contraction (7, 22) . However, in one of these studies mild handgrip contractions were used with only small changes in forearm blood flow of about 100ml/min during exercise, and, therefore, flow changes due to acetylcholine receptor block may not have been detectable. In the second study (7) the role of acetylcholine was specifically examined during a single contraction.
Thus, the aim of the present study was to further assess the role of acetylcholine for skeletal muscle blood flow using the human thigh muscle as experimental model to obtain substantial hyperemia with exercise. We moreover approached the potential role of acetylcholine for muscle vasodilation by using cisatracurium to induce a partial neuromuscular blockade, mainly of slow-twitch fibers (6) . The rationale behind this intervention was that partial neuromuscular blockade during exercise would result in greater release of acetylcholine in order to produce the same amount of work (6, 9, 27) resulting in elevated muscle blood flow.
Muscle blood flow and oxygen uptake were measured and the acetylcholine receptor blocker glycopyrrone was used to examine involvement of acetylcholine in the blood flow response.
Methods
The study encompassed a pilot study and two experimental parts of which the first (Part I) examined the effect of the neuromuscular blocker cisatracurium on muscle blood flow and oxygen uptake during one-legged knee-extensor exercise. In the second (Part II), the role of acetylcholine for the effect of cisatracurium on muscle blood flow was investigated by having subjects performing one-legged exercise without and with cisatracurium alone and with simultaneous infusion of the acetylcholine receptor blocker glycopyrrone .
Subjects
In Part I, nine healthy male subjects ranging in age from 20 to 29 yrs, with an average height of 181 (range: 169-185) cm, and a body mass of 81.5 (59.9-89.2) kg participated. In Part II, five healthy male subjects, ranging in age from 23 to 34 yrs, with a height of 176 (161-183) cm, and a mean body mass of 76.2 (51.7-87.6) kg participated. The subjects were untrained or recreationally active with a maximal oxygen uptake of 48.3 ml min -1 kg -1 (41.2-57.3; part I) and 49.6 ml min -1 kg -1 (42.7-58.1; part II). The subjects were fully informed of the risks and discomforts associated with the experimental procedures, and all provided written consent. The study was carried out in accordance with the guidelines contained in the Declaration of Helsinki and was approved by the Ethics Committee of Copenhagen and
Frederiksberg communities.
Exercise model
Supine one-legged knee-extensor exercise was carried out on an ergometer that permitted the exercise to be confined to the quadriceps muscle (1, 4) . Prior to the study, the subjects made several visits to the laboratory in order to become familiarized with the exercise. After at least two familiarisation sessions, subjects performed incremental exercise in order to determine the maximal power of the knee extensors (64 [56-82] W).
Experimental procedures

Subject preparation-common for Part I and Part II and pilot study
The subjects arrived at the laboratory at 8 am after consuming a standard breakfast and rested in the supine position. Under local anesthesia, one catheter to collect arterial blood samples was placed into the femoral artery of the control left leg and one catheter was placed in the femoral artery of the experimental leg for infusion. 
Experimental protocols for Part I and Part II
The subjects initiated the exercise protocol including a 10-min warm up period at 18 W followed by 30-min of rest and a 10-min bout of exercise at 18 W (Control; CON). 
Part I (CIS)
:
Infusion of cisatracurium, glycopyrron and acetylcholine
Cisatracurium besilate (Nimbex) was a product of GlaxoSmithKline Pharma A/S, (Brøndby, Denmark), Glycopyrrone (Robinul) was a product of Meda AB (Solna, Sweden) and Acetylcholine was a product of ALEXIS Biochemical corporation (San Diego, CA, USA). Cisatracurium was infused at a concentration of 0.2 mg/l thigh volume during the warm up and the 18 W exercise, respectively. 25% of the dose was infused 4 min prior to the exercise, another 25% of the dose 2 min prior to the exercise and 10% of the dose after 1, 3, 5, 7 and 9 min, respectively. Glycopyrrone was administered as bolus infusions of 0.2 mg. Acetylcholine was infused at a dose of 0.14 mg/min/l thigh volume for 2 min.
Pilot study to determine the effect of cisatracurium on fiber type recruitment
In a pilot experiment, we tested the effect of cisatracurium administration on fibre type recruitment during moderate intensity knee-extensor exercise. Six of the subjects performed a 10-min control bout of knee-extensor exercise at 30 W followed by a 10-min exercise bout with cisatracurium infusion using a similar protocol of cisatracurium administration as described above. Biopsies were collected from the medial portion of m. vastus lateralis prior to and immediately after each of the bouts.
The biopsy samples were rapidly frozen and after freeze-drying, fragments of single fibres were manually dissected and identified as ST or FT fibres. An average of 15 fibre fragments of each type were subsequently weighed on a quartz-fibre fish-pole balance and CP content was determined using luminometric analyses with the firefly luciferase method (16, 26 
Measurements and analyses
Thigh blood flow, heart rate and blood pressure Femoral venous blood flow (i.e. thigh blood flow) was measured by the constant infusion thermodilution technique (2) as modified by Gonzalez-Alonzo et al. (13) .
Briefly, venous and infusate temperatures were measured continuously before and during ice-cold saline infusion (10-15 s) at 120 ml min -1 . This resulted in a drop in venous blood temperature of ~0.6-2°C. Resting blood flow measurements were made with an infusion rate of ~30 ml min -1 for 30-45 s. Infusate temperature (0-4°C) was measured at the site of entry to the catheter (Edslab flow-through thermistor).
Venous blood temperature and saline infusate temperatures were recorded at 400
Hz analog-to-digital sampling rate (Powerlab 16s data acquisition system, Chart v4.13 software, AD Instruments, Sydney, Australia). Heart rate was obtained from an electrocardiogram, while arterial blood pressure was monitored with transducers positioned at the level of the heart (Pressure Monitoring Kit, Baxter).
Blood analyses
All arterial and venous blood samples were immediately analysed for pO 2 
Thigh volume and quadriceps muscle mass
The thigh volume and the mass of the quadriceps femoris muscle of the experimental leg were estimated anthropometrically, using measurements of thigh length, circumference and skin fold thickness (14) , and corrected based on a comparison between MR-scan and anthropometric determinations (16) . The quadriceps muscle mass of the experimental leg was 2.4±0.3 kg for the subjects in part I and 2.3±0.5 kg for the subjects in part II.
Calculations
Thigh O 2 uptake and lactate release were calculated by multiplying blood flow with arterial-venous O 2 difference and venous-arterial lactate difference, respectively. A continuous blood flow curve was constructed for each subject by linear interpolation of the measured blood flow data points to obtain time-matched values of blood flow with the blood variables.
Statistics
All data were analyzed using a two-factor (condition x time) repeated measures analysis of variance (ANOVA), with significance set at P<0.05. Significant interactions and main effects were subsequently analyzed using a Newman-Keuls post-hoc test. Data are presented as means±standard error of the mean (SEM), unless otherwise stated. (Fig. 1a) .
Results
Experimental part I
Thigh blood flow
Mean arterial pressure and heart rate
Mean arterial pressure (MAP) at rest was similar in CON and CIS (135±7.2 vs.
133±6.6 mmHg) and during passive movement and onset of exercise (Fig. 1b) . At 90 sec of exercise, MAP was higher (P<0.05) in CIS than in CON (163±6.9 vs. 150±6.6 mmHg) and a ~10% higher level was sustained throughout the exercise bout. Heart rate at rest was 63.4±3.8 and similar for CIS and CON. Heart rate during exercise was higher (P<0.05) in CIS than in CON (115±7 vs.90±3 bpm at 10 min).
Vascular conductance
At rest vascular conductance was similar in CON and CIS (4.5± 2.0 vs. 4.1±0.5 l min -1 mmHg -1 ) and during passive movement of the leg and onset of exercise (Fig. 1c ).
At 90 s of exercise vascular conductance was higher (P<0.05) in CIS than in CON (20.7±1.7 vs. 15.9±1.2 ml min -1 mmHg -1 ). Conductance was also ~20% higher (P<0.05) at 30, 60 and 540 s of exercise in CIS than in CON.
Thigh oxygen uptake
At rest, during passive exercise and in the initial phase of exercise oxygen extraction (a-v diff O 2 ) was not different in CON and CIS, but after 14 s of exercise (79±8 vs.
66±4 ml min -1 ) and throughout the exercise the a-v diff O 2 was higher in CON compared to CIS with the difference at the end of exercise being 19% (130±6 vs.
109±5 ml min -1 ; Fig. 2a ).
Thigh VO 2 was similar in CON and CIS both at rest and during exercise being 328±34 and 333±23 ml min -1 , respectively, after 3 min of exercise, and 354±33 and 406±34 ml min -1 , respectively, at the end of the exercise (Fig. 2b) .
There was no difference in blood pO 2 between CON and CIS.
Blood variables
Blood lactate release increased (P<0.05) similarly from rest to exercise in CON and CIS (from 0.0±0.0 to 1.3±0.4 mmol min -1 and from 0.0±0.1 to 2.0±0.5 mmol min -1 , respectively; Fig. 3 ).
Arterial and venous blood pH levels at rest and during exercise were similar in CON (venous pH: 7.36±0.01 to 7.30±0.01 at 10 min) and CIS (venous pH: 7.36±0.01 to 7.29±0.01 at 10 min).
Arterial and venous blood HCO 3 -levels at rest and during exercise were similar for CON (venous HCO 3 -26.6±0.6 to 29.1±1.3 mmol l -1 at 10 min) and CIS 24.3±0.7
25.4±07 mmol l -1 at 10 min).
Venous plasma potassium levels in CON increased from 4.1±0.1 to 4.3±0.1 mM from rest to exercise and similarly after CIS treatment (3.8±0.1 to 4.1±0.1 mM).
Experimental part II
Resting blood flow and acetylcholine receptor blockade
Prior to the infusion of acetylcholine thigh blood flow was 0.30±0.09 L min 
Combined neuromuscular and acetylcholine receptor blockade
No differences were observed in resting basal muscle blood flow, oxygen extraction or oxygen uptake between CON, CIS and CIS+GLY. The thigh blood flow response to exercise in CIS was higher (P<0.05) than in CON and similar to that in CIS+GLY (Fig. 5a ). Oxygen extraction during exercise in CIS+GLY was similar to that in CIS, but both levels were lower (P<0.05) than in CON. Thigh oxygen uptake in CIS+GLY was not different from either CON or CIS during exercise and recovery (Fig. 5b) .
Discussion
The main finding of the present investigation was that the administration of a competitive neuromuscular blocking reagent enhanced thigh blood flow during exercise by ~30% and thigh vascular conductance by ~20%, without an effect on oxygen uptake. Blood flow and vascular conductance were not altered by inhibition of muscarinic receptors with glycopyrrone. The data suggest that endogenous acetylcholine released from neuromuscular junctions is not essential for exercise hyperemia and, moreover, show that the elevation in blood flow and vascular conductance with neuromuscular blockade are due to factors other than acetylcholine and enhanced oxygen demand.
Partial neuromuscular blockade with CIS specifically blocks slow twitch fibres in animals (18) and in humans (6) and such fiber type specific blockade would require enhanced recruitment of fast twitch (FT) fibers to accomplish a given work load. Thus, the hypothesis of the present study was that partial neuromuscular blockade leads to a greater recruitment of muscle fibres for the same amount of work performed, which would enhance the concentration of acetylcholine in the interstitium (27) and thereby blood flow. To provide evidence for the efficacy of the neuromuscular blockade with cisatracurium, measurements of creatine phosphate in single muscle fibers were conducted in a pilot study in which eight of the subjects in the current study were included. Muscle biopsies were obtained from m. vastus lateralis before and immediately after a bout of 30-W exercise without and with intravenous infusion of cisatracurium. The net CP breakdown in muscle was similar for CON and CIS whereas, in CIS, the drop in average CP content was larger (p<0.05) for FT than for ST fibres (11.7±3.7 mmol/kg d.w.), which was not the case in CON (-5.1±4.4 mmol/kg d.w.; unpublished data). These data suggest that the cisatracurium blockade was effective and that ST fibers were more effectively blocked than FT fibers.
On the assumption that acetylcholine released from the neuromuscular junctions is involved in the regulation of muscle blood flow (21) , the enhanced concentration of acetylcholine due to activation of more fibres would be expected to result in greater vasodilation. The results of the first part of this study support this hypothesis since blockade by cisatracurium induced an elevation in both blood flow and vascular conductance during exercise, compared to exercise in the control situation. However, upon block of acetylcholine receptors with glycopyrrone prior to cisatracurium infusion, no reduction in flow during exercise was observed which suggests that the enhancement in blood flow with cisatracurium was not due to enhanced acetylcholine release. The lack of effect of glycopyrrone was not likely to be due to insufficient inhibition of the acetylcholine receptors, as it was effective in blocking the hyperemic response to acetylcholine by about 90%. Thus, the data show that acetylcholine is a potent vasodilator, but do not support that endogenous release of acetylcholine from the neuromuscular junction is essential for the control of exercise hyperemia in the human leg.
Previous experiments performed on arterioles of hamster cheek pouch have
shown that the acetylcholine analog methacholine is equally effective in causing vasodilation when applied luminally or abluminally (19) , thus acetylcholine released from the neuromuscular junction could mediate vasodilation by acting on either receptor location. In the current experimental design, glycopyrrone was infused intraarterially, and it was assumed that the drug reached both luminal and abluminal muscarinic receptors on the endothelial cells. However, it cannot be fully excluded that glycopyrrone mainly blocked the luminal muscarinic receptors and that the efficacy in blocking acetylcholine from the abluminal side of the arterioles was lower than the 90% determined by acetylcholine infusion. In a study on arterioles of hamster retractor muscle atropine was applied abluminally and was found to reduce the contraction induced vasodilation, which could suggest that extravascular application of a blocker could be more effective (25) . Such an approach would, however, be difficult to apply to humans.
Infusion of cisatracurium did not alter blood pressure at rest, during passive movement of the leg, or in the first minute of exercise but, during the remaining part of the exercise period, blood pressure was approximately 10% higher in CIS compared to CON. This effect corresponds well with the increase observed in previous studies with neuromuscular blockade in humans during exercise (17, 23) and may be explained by enhanced central command and reflex neural mechanisms due to the greater voluntary effort needed to perform the exercise in this condition (10, 17) .
The enhanced blood pressure after neuromuscular blockade in the current study had some effect on leg blood flow during exercise, but could not explain more than part of the difference as evidenced by the greater vascular conductance in the CIS trial during exercise. Central and femoral venous pressure were not determined in the current study, however, only very small alterations in central venous pressure occur during exercise (11) and although it is not possible to exclude that cisatracurium affected venous pressure, it is unlikely that it would have caused an alteration in venous pressure, sufficiently large to explain the observed difference in vascular conductance and blood flow. It could be speculated that cisatracurium may have a direct vasodilatatory effect leading to the increase in blood flow. However, although this possibility cannot be excluded, cisatracurium did not elevate either resting blood flow, flow during passive leg movement, or flow in the first phase of exercise. Therefore, it is more probable that it was the differentiated effect of cisatracurium of FT and ST muscle fibers rather than a direct vasoactive effect that was responsible for the enhanced blood flow. If indeed there is an association between a larger recruitment of FT fibers and the greater hyperemia during cisatracurium administration, this effect is unlikely to be due to an enhanced energy demand, since muscle oxygen uptake was similar in the control and the neuromuscular blockade condition.
Potassium has been suggested to play a role in the control of muscle blood flow (15) , but the finding of slightly lower femoral venous potassium concentrations in CIS compared to CON, suggests that potassium was unlikely to be the cause of the elevated blood flow during exercise with neuromuscular blockade.
In summary, the present study demonstrates that partial neuromuscular blockade with cisatracurium raises blood flow and vascular conductance during exercise without an associated increase in oxygen uptake. The effect was not influenced by acetylcholine receptor blockade suggesting that acetylcholine is not essential for exercise hyperemia and that the elevated blood flow during neuromuscular blockade is not caused by a larger release of acetylcholine. Although the current data are not conclusive on this point, we suggest that exercise hyperemia is greater during greater recruitment of FT as compared to ST muscle fibers.
Perspectives and significance
The results of this study suggest that acetylcholine is not involved in the control of exercise hyperemia or, alternatively, that there may be other vasodilator systems taking over when the action of acetylcholine is impaired by receptor blockade.
Studies investigating the effect of acetylcholine receptor blockade in combination with block of other vasodilator systems would therefore be important. A significant finding in the current study is also that partial neuromuscular blockade enhances exercise hyperemia. This finding is important as it provides evidence for that muscle fiber recruitment and, maybe, in particular enhanced FT fiber recruitment, influences the magnitude of blood flow during exercise. Further studies are needed to explore this possibility.
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